• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Melanoma patients can skip brain, extremity scans

Article

Imaging the brain and uninvolved extremities during routine whole-body PET/CT of melanoma wastes scanner time and exposes patients to unnecessary radiation, according to a study presented at the 2006 Academy of Molecular Imaging meeting.

Imaging the brain and uninvolved extremities during routine whole-body PET/CT of melanoma wastes scanner time and exposes patients to unnecessary radiation, according to a study presented at the 2006 Academy of Molecular Imaging meeting.

At the University of California, Los Angeles, melanoma patients used to undergo routine whole-body scanning. A dedicated PET study could take up to 75 minutes; newer PET/CT exams could be acquired in 30 minutes. A retrospective review of 300 cases found that only a negligible number of patients developed metastases in initially uninvolved extremities and/or the brain. Melanoma patients should be scanned the same way as other oncology patients, a protocol that would improve scanner efficiency without compromising diagnostic power or patient safety, said lead investigator Dr. Esther Choi.

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.